Search hospitals

>

Minnesota

>

Duluth

Essentia Health Saint Mary's Medical Center

Claim this profile

Duluth, Minnesota 55805

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Breast cancer

Conducts research for Non-Small Cell Lung Cancer

Conducts research for Multiple Myeloma

212 reported clinical trials

3 medical researchers

Photo of Essentia Health Saint Mary's Medical Center in DuluthPhoto of Essentia Health Saint Mary's Medical Center in Duluth

Summary

Essentia Health Saint Mary's Medical Center is a medical facility located in Duluth, Minnesota. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Multiple Myeloma and other specialties. Essentia Health Saint Mary's Medical Center is involved with conducting 212 clinical trials across 367 conditions. There are 3 research doctors associated with this hospital, such as Bret E. Friday, Catherine Benziger, MD, MPH, and Bret EB Friday.

Area of expertise

1

Lung Cancer

Global Leader

Essentia Health Saint Mary's Medical Center has run 36 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I
2

Breast Cancer

Global Leader

Essentia Health Saint Mary's Medical Center has run 33 trials for Breast Cancer. Some of their research focus areas include:

ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at Essentia Health Saint Mary's Medical Center

Bladder Cancer

Lung Cancer

Prostate Cancer

Ovarian Cancer

Breast Cancer

Kidney Cancer

Bladder Carcinoma

Pancreatic Cancer

Esophageal cancer

Breast cancer

Image of trial facility.

Pembrolizumab + Radiation

for Bladder Cancer

This phase II trial compares the use of pembrolizumab and radiation therapy to chemotherapy with cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C and radiation therapy for the treatment of non-muscle invasive bladder cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Giving pembrolizumab with radiation may kill more tumor cells than chemotherapy with radiation therapy in patients with non-muscle invasive bladder cancer.

Recruiting

1 award

Phase 2

9 criteria

Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Recruiting

1 award

Phase 2

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Essentia Health Saint Mary's Medical Center?